In this case report from CNS Oncology the authors present a rare case of a patient with multiple recurrent brain metastases of pancreatic origin.
Discover prognostic survival value of pretreatment health-related quality of life (HRQOL) and changes in HRQOL following whole-brain radiation treatment in patients with brain metastases in this research article from CNS Oncology.
Discover how combined-modality hypofractionated radiotherapy could become the new standard of care for elderly patients with glioblastoma in this editorial from Future Science OA.
As part of our Spotlight on neuroregeneration, Lauren Pulling (Editor) spoke to Dr Terry Burns about his work in the field.
Researchers have demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
In a new study published in Scientific Reports, the investigators also reported a higher risk of glioblastoma in Alzheimer’s patients.
A new assay test for five cancer-associated genes with the goal of aiding prediction of neuroblastoma in children has been reported.
Investigators hope that their findings will assist in the development of targeted treatments for pediatric brain cancers.
This review explores the current literature on SRS treatment for both metastatic and benign intradural tumors, with a focus on differential use for intramedullary and intradural extramedullary neoplasms.